These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 29752109)
1. The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites. Ignjatović NL; Penov-Gaši KM; Ajduković JJ; Kojić VV; Marković SB; Uskoković DP Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():371-377. PubMed ID: 29752109 [TBL] [Abstract][Full Text] [Related]
2. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor. Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053 [TBL] [Abstract][Full Text] [Related]
3. Chitosan-PLGA polymer blends as coatings for hydroxyapatite nanoparticles and their effect on antimicrobial properties, osteoconductivity and regeneration of osseous tissues. Ignjatović N; Wu V; Ajduković Z; Mihajilov-Krstev T; Uskoković V; Uskoković D Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():357-364. PubMed ID: 26706541 [TBL] [Abstract][Full Text] [Related]
4. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. Nie H; Wang CH J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077 [TBL] [Abstract][Full Text] [Related]
5. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol. Guo X; Zhang X; Ye L; Zhang Y; Ding R; Hao Y; Zhao Y; Zhang Z; Zhang Y J Drug Target; 2014 Jun; 22(5):421-7. PubMed ID: 24417740 [TBL] [Abstract][Full Text] [Related]
6. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815 [TBL] [Abstract][Full Text] [Related]
8. Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies. Basargan T; Erdol-Aydin N; Nasun-Saygili G J Mater Sci Mater Med; 2017 Oct; 28(11):180. PubMed ID: 28986683 [TBL] [Abstract][Full Text] [Related]
9. Investigating an organ-targeting platform based on hydroxyapatite nanoparticles using a novel in situ method of radioactive ¹²⁵Iodine labeling. Ignjatović N; Vranješ Djurić S; Mitić Z; Janković D; Uskoković D Mater Sci Eng C Mater Biol Appl; 2014 Oct; 43():439-46. PubMed ID: 25175234 [TBL] [Abstract][Full Text] [Related]
10. Poly(d,l-lactide-co-glycolide)-chitosan composite particles for the treatment of lung cancer. Arya N; Katti DS Int J Nanomedicine; 2015; 10():2997-3011. PubMed ID: 25945047 [TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles. Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y Eur J Pharm Sci; 2012 Aug; 47(1):235-43. PubMed ID: 22683651 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of Fe Atila Dinçer C; Yildiz N; Karakeçili A; Aydoğan N; Çalimli A Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1408-1414. PubMed ID: 27855499 [TBL] [Abstract][Full Text] [Related]
13. Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model. Wahba SM; Darwish AS; Kamal SM Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():151-63. PubMed ID: 27157738 [TBL] [Abstract][Full Text] [Related]
14. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
16. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614 [TBL] [Abstract][Full Text] [Related]
17. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303 [TBL] [Abstract][Full Text] [Related]
18. [Preparation and characterization of tetrandrine-loaded PLGA nanocomposite particles by premix membrane emulsification coupled with spray-drying method]. Hu T; Zhu HX; Guo LW; Pan LM; Li B; Shi FY; Lu J Yao Xue Xue Bao; 2014 Nov; 49(11):1607-13. PubMed ID: 25757290 [TBL] [Abstract][Full Text] [Related]
19. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(L-lactide). Zhang P; Hong Z; Yu T; Chen X; Jing X Biomaterials; 2009 Jan; 30(1):58-70. PubMed ID: 18838160 [TBL] [Abstract][Full Text] [Related]